reference/32698026

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32698026

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, U.S. Gov't, P.H.S.
endingPage	1736
issn	0008-543X 1097-0142
issueIdentifier	10
pageRange	1731-1736
publicationName	Cancer
startingPage	1731
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_abfcbbcf300cc059c6faf5e988895177 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c286c8f1824f3bc0c7175bc5850ba5e1 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0421371de1e86440330b4916f05fc013
bibliographicCitation	Martenson JA, Lipsitz SR, Lefkopoulou M, Engstrom PF, Dayal YY, Cobau CD, Oken MM, Haller DG. Results of combined modality therapy for patients with anal cancer (E7283). An Eastern Cooperative Oncology Group study. Cancer. 1995 Nov 15;76(10):1731–6. doi: 10.1002/1097-0142(19951115)76:10<1731::aid-cncr2820761009>3.0.co;2-h. PMID: 8625041.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_085d208a2003588ddae8be511ebd3fc4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_19c6dc6492da56017bf2f933093c66f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae81b071ec8c10c49ea6086db9e18eed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c07bb5443df58b3912ca1ea5f2c76b8c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51dfe8151eb83181a5916cedbd3d56bf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_88bf528b2ad4ff45b6cfafda8f9b7656 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74bc7a07f756379cf13db6b0a0067671 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b20eed44b333325c9bb6f300f7053d30
date	1995-11-15^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1002/1097-0142%2819951115%2976:10%3C1731::aid-cncr2820761009%3E3.0.co%3B2-h https://pubmed.ncbi.nlm.nih.gov/8625041
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2771 https://portal.issn.org/resource/ISSN/1097-0142 https://portal.issn.org/resource/ISSN/0008-543X
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Results of combined modality therapy for patients with anal cancer (E7283). An eastern cooperative oncology group study
discusses	http://id.nlm.nih.gov/mesh/M0013948 http://id.nlm.nih.gov/mesh/M0008631
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D001005Q000628
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D001005Q000401 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D005472Q000008 http://id.nlm.nih.gov/mesh/D003131 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D016685Q000008 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D011446
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6921 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5746 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3385 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Showing number of triples: 1 to 52 of 52.